Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/03/1998US5723759 Pyrrolnitrin biosynthesis genes
03/03/1998US5723758 Bacillus thuringiensis genes encoding lepidopteran-active toxins
03/03/1998US5723756 Genetic engineering
03/03/1998US5723755 Biosynthesis
03/03/1998US5723754 Tapetum-specific promoters from Brassicaceae spp
03/03/1998US5723750 Viricides, genetic engineering
03/03/1998US5723601 Stirring water based solutions with organic solvents and pore forming organic phase
03/03/1998US5723598 Encoded combinatorial chemical libraries
03/03/1998US5723594 High affinity PDGF nucleic acid ligands
03/03/1998US5723592 Evolution of products from nucleic acids
03/03/1998US5723588 Heat stable resin with polypeptides such as elastin, collagen with keratin or silk proteins
03/03/1998US5723585 Method of purifying cardiac hypertrophy factor
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723582 Immunology and autoimmune diseases
03/03/1998US5723581 Murine and human box-dependent myc-interacting protein (Bin1)
03/03/1998US5723579 Fibrinogen binding peptides
03/03/1998US5723578 Peptide analogs of bombesin
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723576 Polypeptides for enzyme inhibitors and hirundin
03/03/1998US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
03/03/1998US5723442 Peptide derivatives
03/03/1998US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3
03/03/1998US5723440 Insecticides and pesticides
03/03/1998US5723438 Administering the soluble antiviral domain of the ldl receptor protein of seq id no:2 or a salt, derivative or mutant thereof
03/03/1998US5723437 Glycoproteins and cell surfaces and scavenger receptors
03/03/1998US5723436 Immunosuppressants
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/03/1998US5723333 Vectors of oncogenes, promoters, transcription
03/03/1998US5723332 Translational enhancer DNA
03/03/1998US5723329 DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells
03/03/1998US5723326 Genome coding phytolacca antiviral protein and a recombinant expression vector therefor
03/03/1998US5723323 Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof
03/03/1998US5723319 Cultured cell line that inducibly expresses the hepatitis B virus genome, and uses thereof for screening antiviral substances
03/03/1998US5723318 DNA coding for megakaryocyte potentiator
03/03/1998US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723314 Antigens and antibodies and peptides
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723312 Derived from insect triatoma; anticoagulants; antitumor, anticarcinogenic, and antimetastasis agents; genetic engineering
03/03/1998US5723310 Aqueous multiple-phase isolation of polypeptide
03/03/1998US5723309 Production of subunits of soluble T cell receptors by co-transfection
03/03/1998US5723303 Immunoglobulin a binding protein
03/03/1998US5723299 Somatostatin receptors
03/03/1998US5723292 Stable DNA constructs
03/03/1998US5723291 Methods for screening compounds for estrogenic activity
03/03/1998US5723289 Parallel selex
03/03/1998US5723286 Peptide library and screening systems
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723128 Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
03/03/1998US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody
03/03/1998US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
03/03/1998US5723121 Sugar modified interferon
03/03/1998US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists
03/03/1998US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4
03/03/1998US5723117 Use of interleukin-1 (IL-1) to inhibit development of hepatitis
03/03/1998CA1339700C Process and entermediates for anf peptide
03/03/1998CA1339694C Human high-affinity neurotranmitter uptake system
02/1998
02/26/1998WO1998008098A2 Assaying d-amino acids in body fluids
02/26/1998WO1998007886A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007880A1 Human endokine alpha
02/26/1998WO1998007878A2 Long-term expression of gene products by transforming muscle cells
02/26/1998WO1998007877A1 A short-shafted adenoviral fiber and its use
02/26/1998WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression
02/26/1998WO1998007875A1 Method for inducing viral resistance into a plant
02/26/1998WO1998007873A1 Yeast vectors and process for producing proteins with the use of the same
02/26/1998WO1998007866A1 Antigenic protein originating in infectious laryngotracheitis virus
02/26/1998WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007863A1 HUMAN INTERFERON τ VARIANTS
02/26/1998WO1998007862A2 Chemokine beta-16
02/26/1998WO1998007861A1 Anti-proliferative factor from transfected cells
02/26/1998WO1998007860A1 HUMAN POLYHOMEOTIC 1 (hph1) ACTS AS AN ONCOGENE
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007858A1 HUMAN POLYHOMEOTIC 1(hphl) ACTS AS A TUMOR SUPPRESSOR
02/26/1998WO1998007857A1 Reagents and methods useful for detecting diseases of the breast
02/26/1998WO1998007856A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007854A1 Human glycine transporter
02/26/1998WO1998007853A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007852A1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination
02/26/1998WO1998007851A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007849A1 Madr2 tumour suppressor gene
02/26/1998WO1998007847A1 M. tuberculosis complex members mycobacteria specific nucleic acid fragments and their applications for the detection and differential diagnosis of m. tuberculosis complex members
02/26/1998WO1998007844A2 SCREENING ASSAY FOR THE IDENTIFICATION OF AGENTS WHICH ALTER EXPRESSION OF PTH-rP
02/26/1998WO1998007842A1 Methods for improving seeds
02/26/1998WO1998007840A1 Novel dnas and process for producing proteins by using the same
02/26/1998WO1998007835A2 Crystal structures of a protein tyrosine kinase
02/26/1998WO1998007833A1 Compositions and methods for use of defensin
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007830A2 COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
02/26/1998WO1998007754A1 T1 receptor-like ligand ii
02/26/1998WO1998007753A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
02/26/1998WO1998007752A1 Self-assembling amphiphiles for construction of peptide secondary structures
02/26/1998WO1998007751A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
02/26/1998WO1998007750A1 Novel osteopontin derived chemotactic peptides and methods of use
02/26/1998WO1998007749A1 Novel human growth factors
02/26/1998WO1998007748A2 Plag gene family and tumorigenesis
02/26/1998WO1998007747A1 Transformed wheat having improved breadmaking characteristics